Key result
Hypertension increases the risk of cognitive impairment, while antihypertensive drug therapy is associated with a 30% lower incidence of dementia compared to no treatment in older adults.
Why the study?
Does antihypertensive drug therapy reduce the risk of cognitive impairment and dementia in persons with hypertension?
Does antihypertensive drug therapy reduce the risk of cognitive impairment and dementia in persons with hypertension?
This review highlights that hypertension is a significant risk factor for cognitive impairment and dementia, and that antihypertensive therapy may mitigate this risk.
Numerous studies have demonstrated that hypertension increases the risk for cognitive impairment, vascular dementia, and Alzheimer’s disease (1-11). In a 5-year longitudinal study of 353 community-dwelling persons, mean age 72 years, increased blood pressure variability was associated with poorer cognitive function (5). In a study of 1,373 persons aged 59 to 71 years of age in France, the risk of cognitive impairment at 4-year assessment was increased 2.8 times in persons with hypertension (2). In persons with hypertension, the risk of cognitive impairment was increased 4.3 times in persons who were not treated with antihypertensive drug therapy versus increased 1.9 times in persons treated with antihypertensive drug therapy (2). In a study of 1,301 persons aged 75 years and older without dementia, at 3-year mean follow-up, persons with hypertension treated with antihypertensive drug therapy had a 30% lower incidence of dementia than persons with hypertension not treated with antihypertensive drug therapy (1).
No takes yet. Share an insight, caveat, or question.
Wilbert S. Aronow (2017) conducted a review in Hypertension and cognitive impairment. Antihypertensive drug therapy vs. No antihypertensive drug therapy was evaluated on Cognitive impairment and dementia. Hypertension increases the risk of cognitive impairment, while antihypertensive drug therapy is associated with a 30% lower incidence of dementia compared to no treatment in older adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: